What is the recommended treatment for Mycoplasma genitalium infection in an adult male?

Treatment of Mycoplasma genitalium in Adult Males

For initial treatment of M. genitalium infection in an adult male, use azithromycin 500 mg orally on day 1, followed by 250 mg once daily for days 2-5 (extended 5-day regimen). This recommendation is based on the most recent high-quality guidelines that prioritize macrolide resistance-guided therapy while acknowledging the superior efficacy of azithromycin over doxycycline for M. genitalium 1, 2.

Initial Treatment Approach

The evidence consistently demonstrates that M. genitalium responds better to azithromycin than doxycycline, with cure rates of 85-95% for macrolide-susceptible infections versus only 30-40% for doxycycline 3, 1, 4. While older 2010 CDC guidelines listed both as equivalent options for non-gonococcal urethritis, they specifically noted M. genitalium's preferential response to azithromycin 3.

Recommended First-Line Regimen:

• Azithromycin 500 mg orally on day 1, then 250 mg once daily for days 2-5 (total 2.5 g over 5 days) 1, 5, 4

This extended azithromycin regimen is superior to the older single 1 g dose, which contributed to widespread macrolide resistance development 1, 4.

Critical Considerations for Treatment Success

Macrolide Resistance Testing

The single most important factor affecting treatment outcomes is macrolide resistance, which now affects 68% or more of M. genitalium infections in some populations 6. The 2021 European guideline emphasizes that diagnosis "must include investigation for macrolide resistance mutations" 1. However, if resistance testing is unavailable, proceed with the extended azithromycin regimen as first-line therapy 5.

Sexual Abstinence

Instruct the patient to abstain from sexual intercourse for 7 days after completing therapy AND until all partners are treated to prevent reinfection 3.

Treatment Failure or Recurrence

If symptoms persist or M. genitalium is detected on test-of-cure (performed 3 weeks after treatment completion 5):

Second-Line Treatment:

Doxycycline 100 mg orally twice daily for 7 days, followed immediately by:

• If macrolide-susceptible or unknown: Azithromycin 1 g on day 1, then 500 mg once daily for 3 days 5, 6
• If macrolide-resistant: Moxifloxacin 400 mg once daily for 7 days 1, 5, 4

The doxycycline pre-treatment reduces bacterial load by approximately 2.6 log10 and may decrease selection of macrolide resistance, even though it doesn't cure the infection alone 6.

Why Moxifloxacin for Resistant Cases:

Moxifloxacin achieves 92% cure rates for macrolide-resistant infections 6 and is the most effective second-line agent 7. A 2024 New York study found moxifloxacin had 82% microbiologic cure versus only 41% for azithromycin regimens, with 4 times the odds of cure (aOR 4.18) 7.

Important Caveats and Pitfalls

Avoid These Common Mistakes:

1. Don't use azithromycin 1 g single dose - this older regimen has lower efficacy and drives resistance 1, 4
2. Don't use doxycycline monotherapy - cure rates are only 30-40% 1, 4
3. Don't skip test-of-cure - perform 3 weeks after treatment completion to detect treatment failure 5
4. Don't forget partner treatment - all partners within 60 days require evaluation and empiric treatment 3

Moxifloxacin Warnings:

Recent guidelines have narrowed moxifloxacin indications due to FDA warnings about serious side effects (tendon rupture, peripheral neuropathy, aortic dissection) 1. Reserve it for confirmed macrolide-resistant infections or documented treatment failures.

Third-Line Options for Persistent Infection

If both azithromycin and moxifloxacin fail:

• Doxycycline or minocycline 100 mg twice daily for 14 days - may cure 40-70% 1
• Pristinamycin 1 g four times daily for 10 days - approximately 75% cure rate 1, 4

A 2025 case report documented successful cure with tinidazole 2 g daily for 7 days after multiple treatment failures 8, though this remains experimental.

Partner Management

All sexual partners within the preceding 60 days must be evaluated and treated empirically with a regimen effective against M. genitalium 3. Use the same extended azithromycin regimen for partners, regardless of symptoms.

Additional Testing

Screen all patients diagnosed with M. genitalium for:

• Gonorrhea and chlamydia (co-infection is common)
• Syphilis
• HIV 3